not supported for this round: a leading life sciences investment fund
Sources agree. The release identifies the third co-lead only as “an undisclosed leading life sciences investment fund” and lists the other named participants; “and others” is not included as a specific investor.
[ BUILT WITH ]·[ SEARCH ]found by Firecrawl search: "Series D" raises million·[ SCRAPE ]4 pages read: globenewswire.com, investing.com, manilatimes.net·[ JSON ]round extracted with a schema, grounded to one sentence·[ VERIFY ]correctedread back across 1 source·[ BRANDING ]logo and colour from the homepage·[ ALEXANDRIA ]firmographics from FullEnrich via Alexandria·[ AGENT ]dossier built by the Firecrawl agent
Series C
$102M · 2024-12-16
Verified against 1 source[ HISTORY ]: An earlier round of this company, found through its checked dossier and read from its own announcement like any round. Not news: never sent, and left out of the feed unless you filter by date.
Sources agree. The source names Duquesne Family Office as the investor and identifies it as the investment firm of Stanley F. Druckenmiller; therefore the investor is listed as Duquesne Family Office, not Stanley F. Druckenmiller personally.
Series B
$41M · 2023-01-25
Verified against 1 source[ HISTORY ]: An earlier round of this company, found through its checked dossier and read from its own announcement like any round. Not news: never sent, and left out of the feed unless you filter by date.
Sources agree. Steadview Capital and B Capital Group are included because the release says they participated in the round alongside the other investors.
Series ASeries A Financing
$12M · 2021-05-25
Verified against 1 source[ HISTORY ]: An earlier round of this company, found through its checked dossier and read from its own announcement like any round. Not news: never sent, and left out of the feed unless you filter by date.
Sources agree. The release states that Precision Neuroscience has offices in New York, California, and Massachusetts, but does not identify a headquarters.
not supported for this round: a leading life sciences investment fund
Sources agree. The release identifies the third co-lead only as “an undisclosed leading life sciences investment fund” and lists the other named participants; “and others” is not included as a specific investor.
Dossier
[ CHECKED ]
Fetched today
Precision Neuroscience builds Layer 7, a minimally invasive, removable brain-computer interface that records brain activity and is intended to let people with paralysis control digital devices with their thoughts.
Founders
Benjamin Rapoport · Chief Science Officer, Co-Founder
Before founding Precision, he was a co-founder of Neuralink; he holds an MD from Harvard Medical School and a PhD in electrical engineering and computer science from MIT.
Mark Hettick · Co-founder and VP of Engineering
Founded
2021
Total raised
$430 million
Backers
Duquesne Family Office, Steadview Capital Management, Forepont Capital Partners, Alumni Ventures, Draper Associates, re.Mind Capital, General Equity Holdings
PRIOR ROUNDS
Round
Amount
Announced
Lead
Series A Financing
$12 million
2021-05-25
Steadview Capital, B Capital Group's Ascent Team
Series B
$41 million
2023-01-25
Forepont Capital Partners
Series C
$102 million
2024-12-16
General Equity Holdings
WHY IT MATTERS
Precision says its Layer 7 interface is minimally invasive, safely removable, and high-bandwidth, and its latest release reports more than 100 patient procedures across 18 medical institutions plus FDA clearance. The $250 million Series D brings total capital raised to $430 million and is intended to expand clinical programs, advance further FDA review, and build commercialization infrastructure for people with neurological injuries.
Precision Neuroscience Corporation sells brain-computer interface technology aimed at helping people with paralysis operate digital devices using their thoughts.
Founded
2021
Headcount
130
Type
Privately Held
Industry
Medical Equipment Manufacturing
Via Alexandria from FullEnrich: founded, headcount, type, industry
[ BUILT WITH ]·[ SEARCH ]found by Firecrawl search: history: Precision Neuroscience Corporation·[ SCRAPE ]1 page read: globenewswire.com·[ JSON ]round extracted with a schema, grounded to one sentence·[ VERIFY ]confirmedread back across 1 source·[ BRANDING ]logo and colour from the homepage·[ ALEXANDRIA ]firmographics from FullEnrich via Alexandria·[ AGENT ]dossier built by the Firecrawl agent
[ BUILT WITH ]·[ SEARCH ]found by Firecrawl search: history: Precision Neuroscience Corporation·[ SCRAPE ]1 page read: globenewswire.com·[ JSON ]round extracted with a schema, grounded to one sentence·[ VERIFY ]confirmedread back across 1 source·[ BRANDING ]logo and colour from the homepage·[ ALEXANDRIA ]firmographics from FullEnrich via Alexandria·[ AGENT ]dossier built by the Firecrawl agent
[ BUILT WITH ]·[ SEARCH ]found by Firecrawl search: history: Precision Neuroscience Corporation·[ SCRAPE ]1 page read: prnewswire.com·[ JSON ]round extracted with a schema, grounded to one sentence·[ VERIFY ]confirmedread back across 1 source·[ BRANDING ]logo and colour from the homepage·[ ALEXANDRIA ]firmographics from FullEnrich via Alexandria·[ AGENT ]dossier built by the Firecrawl agent
[ BUILT WITH ]
·[ SEARCH ]found by Firecrawl search: "Series D" raises million
·[ JSON ]round extracted with a schema, grounded to one sentence
·[ VERIFY ]correctedread back across 1 source
·[ BRANDING ]logo and colour from the homepage
·[ ALEXANDRIA ]firmographics from FullEnrich via Alexandria
·[ AGENT ]dossier built by the Firecrawl agent
Series C
Verified against 1 source[ HISTORY ]: An earlier round of this company, found through its checked dossier and read from its own announcement like any round. Not news: never sent, and left out of the feed unless you filter by date.
Sources agree. The source names Duquesne Family Office as the investor and identifies it as the investment firm of Stanley F. Druckenmiller; therefore the investor is listed as Duquesne Family Office, not Stanley F. Druckenmiller personally.
[ BUILT WITH ]·[ SEARCH ]found by Firecrawl search: history: Precision Neuroscience Corporation·[ SCRAPE ]1 page read: globenewswire.com·[ JSON ]round extracted with a schema, grounded to one sentence·[ VERIFY ]confirmedread back across 1 source·[ BRANDING ]logo and colour from the homepage·[ ALEXANDRIA ]firmographics from FullEnrich via Alexandria·[ AGENT ]dossier built by the Firecrawl agent
Series B
Verified against 1 source[ HISTORY ]: An earlier round of this company, found through its checked dossier and read from its own announcement like any round. Not news: never sent, and left out of the feed unless you filter by date.
Sources agree. Steadview Capital and B Capital Group are included because the release says they participated in the round alongside the other investors.
[ BUILT WITH ]·[ SEARCH ]found by Firecrawl search: history: Precision Neuroscience Corporation·[ SCRAPE ]1 page read: globenewswire.com·[ JSON ]round extracted with a schema, grounded to one sentence·[ VERIFY ]confirmedread back across 1 source·[ BRANDING ]logo and colour from the homepage·[ ALEXANDRIA ]firmographics from FullEnrich via Alexandria·[ AGENT ]dossier built by the Firecrawl agent
Series A
Series A Financing
Verified against 1 source[ HISTORY ]: An earlier round of this company, found through its checked dossier and read from its own announcement like any round. Not news: never sent, and left out of the feed unless you filter by date.
Sources agree. The release states that Precision Neuroscience has offices in New York, California, and Massachusetts, but does not identify a headquarters.
[ BUILT WITH ]·[ SEARCH ]found by Firecrawl search: history: Precision Neuroscience Corporation·[ SCRAPE ]1 page read: prnewswire.com·[ JSON ]round extracted with a schema, grounded to one sentence·[ VERIFY ]confirmedread back across 1 source·[ BRANDING ]logo and colour from the homepage·[ ALEXANDRIA ]firmographics from FullEnrich via Alexandria·[ AGENT ]dossier built by the Firecrawl agent
